Skip to content

Dogwood Therapeutics DWTX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$4.99M-31.9%-$3.78M+76.0%-$15.74M-314%-$3.81M+65.1%-$10.92M-41.4%
$17.26K+1.4%$17.02K+459%
$449.42K+185%$157.86K+227%$48.28K-25.8%$65.03K-23.0%$84.47K-9.9%
-$4.59M-26.1%-$3.64M-11.1%-$3.27M+18.7%-$4.03M+14.0%-$4.68M+23.6%
$11.29M+34,577%$32.56K$7.37M-51.9%
$6.7M+286%-$3.6M-10.1%-$3.27M+21.1%-$4.15M-254%$2.69M-79.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Dogwood Therapeutics generate?
Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
Where does Dogwood Therapeutics's cash flow data come from?
Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.